SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Holdings
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Louie Romano who wrote (116)7/26/1998 9:26:00 PM
From: jacq   of 224
 
Louie that wasn't me. I am still very positive on the stock and have been making recommendations to my friends. I have a stable of investments which need feeding. It is sometimes difficult to know which horse is going to go around the track the fastest. There are some fantastic technologies out there that fascinate me. I buy what I believe will change lives and improve humanities lot. I also like to see companies that can take these technologies and develop them so that they are saleable in the marketplace. That is sometimes a very hard thing to do. I was very much afraid to invest in this company when every quarter they spent more money and the abyss seemed to be closer and closer. The fact that they are cashflow positive means a tremendous amount to me. It means that they have the breathing space to get their Diab II ( or V-411) trials done without having to give up most of the company to raise financing.

If this product gets to the world market and if it is as good as it is claimed to be this company will one day become a major. pharmaceutical. That quote by Morgan Grenfell that you alluded to where they stated that Diab II could achieve sales of $199,000,000 per year was also a great comfort. One more item of course is Diab II has a very low toxicity profile. No one so far has discontinued using the product because of any health problems. It seems possible to me though I am no expert that the product might do better than the Morgan Grenfell estimate because of how well it is tolerated. Then there is Diab II's ability to help control colestoral.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News